Tien Wee Luk
Chief Clinical OfficerDr. Tien Wee Luk serves as the Chief Clinical Officer of CytoMed Therapeutics Limited since April 18, 2013 and was its Director from January 2021 until May 15, 2024. He is the designated Principal Investigator for registered Phase I Clinical Trials in Malaysia, focusing on Mesenchymal Stem Cell Therapy and CAR-T Cell therapy. Dr. Luk also serves as a member of the Science Industry Advisory Committee for PSB Academy’s School of Life Sciences (Singapore) since 2019. He is the Medical Director and Consultant Obstetrician & Gynaecologist (O&G) and founding Chairman of the Independent Ethics Committee at LMC, a private licensed hospital in Malaysia since 2019. He is the appointed Johor State Representative for Obstetrics & Gynaecology from September 2024 to August 2026. Professional and Academic Roles: Dr. Luk has held the position of Secretary for the Royal College of Obstetricians & Gynaecologists (RCOG) International Representative Committee (IRC) Malaysia from 2018 until October 2021. He is actively involved in medical education and has served on the central planning and training committee for the Malaysian National MRCOG Parallel Pathway Programme for Malaysian doctors training in Obstetrics & Gynaecology since November 2017. He is an invited medical lecturer at Monash University (Johor Campus) since March 2021. Areas of Interest and Certification: Dr. Luk has a keen interest in cellular therapy and has attended numerous certificate courses pertaining to clinical cell therapy. He holds a Good Clinical Practice qualification. Education: Dr. Luk received his M.D. MRCOG (UK) from the Royal College of Obstetricians & Gynaecologists (United Kingdom) in 2016 and MB BCh BAO from the Royal College of Surgeons (Ireland) in 2008. He obtained a Diploma in Cosmetic Gynaecology (DDAG) in May 2024 and a Fertility Fellowship (UKSH) in May 2023.
Positions
- Company NameCytoMed Therapeutics LimitedStock CodeGDTCPositionChief Clinical Officer
